X
EVH icon

Xponance’s Evolent Health EVH Stock Holding History

Xponance’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.2K Buy
10,918
+394
+4% +$1.51K ﹤0.01% 1774
2026
Q1 		$24K Buy
+10,524
New +$33.4K ﹤0.01% 1668
2024
Q4 		– Sell
-7,584
Closed -$214K – 1452
2024
Q3 		$214K Buy
+7,584
New +$195K ﹤0.01% 1223
2024
Q2 		– Sell
-6,807
Closed -$223K – 1333
2024
Q1 		$223K Buy
6,807
+98
+1% +$3.13K ﹤0.01% 1152
2023
Q4 		$222K Buy
+6,709
New +$190K ﹤0.01% 1127

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Xponance's EVH Position: Q2 2026 in Review

Xponance increased its Evolent Health (EVH) stake by 3.7% in Q2 2026, buying an estimated $1.51K and bringing the position to 10,918 shares worth $59.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Xponance first reported a position in EVH in Q4 2023 and has held it in 5 quarters since. The position peaked at $223K in Q1 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Xponance held 10,918 shares of Evolent Health worth $59.2K as of Q2 2026.
  • Xponance bought 394 Evolent Health shares in Q2 2026, an estimated $1.51K.
  • Evolent Health made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1774 holding.
  • Xponance first reported a position in Evolent Health in Q4 2023 and has held it in 5 quarters since.
  • Xponance's Evolent Health position peaked at $223K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.